Table 4.
Factors associated with HPV vaccine uptake, multimodel averaging approach (France, 2016)
| Partial R2 | aOR#[95% CI] | Weight* | Evidence | Rank | |
|---|---|---|---|---|---|
| Clusters | 0.13 | ||||
| Cluster 1 | 1 | 1.000 | Very strong | 1 | |
| Cluster 2 | 0.15 [0.11;0.20] | ||||
| Cluster 3 | 0.49 [0.40;0.61] | ||||
| Cluster 4 | 0.27 [0.17;0.42] | ||||
| Gender/age | 1.000 | Very strong | 2 | ||
| Young women | |||||
| 15–19 years old | 1 | ||||
| 20–25 years old | 1.98 [1.50;2.61] | ||||
| Parents of young women: | |||||
| Women | 0.07 | ||||
| 26–45 years old | 0.60 [0.45;0.80] | ||||
| > 46 years old | 0.79 [0.57;1.09] | ||||
| Men | |||||
| 25–45 years old | 0.41 [0.27;0.62] | ||||
| > 45 years old | 0.65 [0.46;0.92] | ||||
| Favorable to vaccination in general: | 1.000 | Very strong | 3 | ||
| Absolutely/Somewhat | 0.02 | 1 | |||
| Not really/Not at all | 2.27 [1.73;2.96] | ||||
| Educational level | 0.580 | Weak | 4 | ||
| < High-school | 0.00 | 1 | |||
| High-school | 1.18 [0.94;1.49] | ||||
| 1–3 years completed at university | 1.09 [0.83;1.42] | ||||
| > 3 years completed at university | 0.76 [0.54;1.07] | ||||
| Household Income | 0.00 | 0.190 | None | 5 | |
| Low | 1 | ||||
| Medium | 0.83 [0.66;1.04] | ||||
| High | 0.98 [0.75;1.28] | ||||
| no answer | 0.89 [0.61;1.31] | ||||
*According to Viallefont’s classification [0–0.5]: no evidence; [0.5–0.75]: weak evidence; [0.75–0.90]: positive evidence; [0.95–0.99]: strong evidence; [0.99–1]: very strong evidence
# adjusted odds ratio